{"id":38681,"date":"2019-03-26T07:45:32","date_gmt":"2019-03-26T12:45:32","guid":{"rendered":"https:\/\/www.t3live.com\/blog\/?p=38681"},"modified":"2019-03-26T07:45:32","modified_gmt":"2019-03-26T12:45:32","slug":"options-in-play-busy-in-biotech","status":"publish","type":"post","link":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/","title":{"rendered":"Options In Play &#8211; Busy In Biotech"},"content":{"rendered":"<p>Last week was a busy one for Biotech with some key pipeline updates and big movers. This week has started off with some action and more news is expected as we head into quarter end.<\/p>\n<p><iframe style=\"border: none; overflow: hidden;\" src=\"https:\/\/www.facebook.com\/plugins\/video.php?href=https%3A%2F%2Fwww.facebook.com%2FT3Live%2Fvideos%2F394346631347213%2F&show_text=0&width=560\" width=\"560\" height=\"315\" frameborder=\"0\" scrolling=\"no\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Last week was a busy one for Biotech with some key pipeline updates and big movers. This week has started off with some action and more news is expected as we head into quarter end.<\/p>\n","protected":false},"author":26,"featured_media":34095,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-38681","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-options-trading"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Options In Play - Busy In Biotech - T3 Live<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Options In Play - Busy In Biotech - T3 Live\" \/>\n<meta property=\"og:description\" content=\"Last week was a busy one for Biotech with some key pipeline updates and big movers. This week has started off with some action and more news is expected as we head into quarter end.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/\" \/>\n<meta property=\"og:site_name\" content=\"T3 Live\" \/>\n<meta property=\"article:published_time\" content=\"2019-03-26T12:45:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1599\" \/>\n\t<meta property=\"og:image:height\" content=\"837\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Daniel Darrow\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daniel Darrow\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/\"},\"author\":{\"name\":\"Daniel Darrow\",\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/person\/58d67d1c15041631b5efd79b7c58808a\"},\"headline\":\"Options In Play &#8211; Busy In Biotech\",\"datePublished\":\"2019-03-26T12:45:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/\"},\"wordCount\":42,\"publisher\":{\"@id\":\"https:\/\/blog.t3live.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg\",\"articleSection\":[\"Options\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/\",\"url\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/\",\"name\":\"Options In Play - Busy In Biotech - T3 Live\",\"isPartOf\":{\"@id\":\"https:\/\/blog.t3live.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg\",\"datePublished\":\"2019-03-26T12:45:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#primaryimage\",\"url\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg\",\"contentUrl\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg\",\"width\":1599,\"height\":837},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/blog.t3live.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Options In Play &#8211; Busy In Biotech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.t3live.com\/#website\",\"url\":\"https:\/\/blog.t3live.com\/\",\"name\":\"T3 Live\",\"description\":\"Real Traders, Real Time\",\"publisher\":{\"@id\":\"https:\/\/blog.t3live.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.t3live.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/blog.t3live.com\/#organization\",\"name\":\"T3 Live\",\"url\":\"https:\/\/blog.t3live.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2026\/09\/T3-Live-Logo-white.png\",\"contentUrl\":\"https:\/\/blog.t3live.com\/wp-content\/uploads\/2026\/09\/T3-Live-Logo-white.png\",\"width\":658,\"height\":292,\"caption\":\"T3 Live\"},\"image\":{\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/person\/58d67d1c15041631b5efd79b7c58808a\",\"name\":\"Daniel Darrow\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blog.t3live.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cb9d48ddf1a79dac82367bb5c22611feaedc4d64d36c4bdb145788669605ab60?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cb9d48ddf1a79dac82367bb5c22611feaedc4d64d36c4bdb145788669605ab60?s=96&d=mm&r=g\",\"caption\":\"Daniel Darrow\"},\"url\":\"https:\/\/blog.t3live.com\/author\/daniel-darrow\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Options In Play - Busy In Biotech - T3 Live","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/","og_locale":"en_US","og_type":"article","og_title":"Options In Play - Busy In Biotech - T3 Live","og_description":"Last week was a busy one for Biotech with some key pipeline updates and big movers. This week has started off with some action and more news is expected as we head into quarter end.","og_url":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/","og_site_name":"T3 Live","article_published_time":"2019-03-26T12:45:32+00:00","og_image":[{"width":1599,"height":837,"url":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg","type":"image\/jpeg"}],"author":"Daniel Darrow","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Daniel Darrow"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#article","isPartOf":{"@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/"},"author":{"name":"Daniel Darrow","@id":"https:\/\/blog.t3live.com\/#\/schema\/person\/58d67d1c15041631b5efd79b7c58808a"},"headline":"Options In Play &#8211; Busy In Biotech","datePublished":"2019-03-26T12:45:32+00:00","mainEntityOfPage":{"@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/"},"wordCount":42,"publisher":{"@id":"https:\/\/blog.t3live.com\/#organization"},"image":{"@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg","articleSection":["Options"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/","url":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/","name":"Options In Play - Busy In Biotech - T3 Live","isPartOf":{"@id":"https:\/\/blog.t3live.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#primaryimage"},"image":{"@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg","datePublished":"2019-03-26T12:45:32+00:00","breadcrumb":{"@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#primaryimage","url":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg","contentUrl":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2018\/09\/options-slider-new.jpg","width":1599,"height":837},{"@type":"BreadcrumbList","@id":"https:\/\/blog.t3live.com\/2019\/03\/26\/options-in-play-busy-in-biotech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blog.t3live.com\/"},{"@type":"ListItem","position":2,"name":"Options In Play &#8211; Busy In Biotech"}]},{"@type":"WebSite","@id":"https:\/\/blog.t3live.com\/#website","url":"https:\/\/blog.t3live.com\/","name":"T3 Live","description":"Real Traders, Real Time","publisher":{"@id":"https:\/\/blog.t3live.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.t3live.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blog.t3live.com\/#organization","name":"T3 Live","url":"https:\/\/blog.t3live.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.t3live.com\/#\/schema\/logo\/image\/","url":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2026\/09\/T3-Live-Logo-white.png","contentUrl":"https:\/\/blog.t3live.com\/wp-content\/uploads\/2026\/09\/T3-Live-Logo-white.png","width":658,"height":292,"caption":"T3 Live"},"image":{"@id":"https:\/\/blog.t3live.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blog.t3live.com\/#\/schema\/person\/58d67d1c15041631b5efd79b7c58808a","name":"Daniel Darrow","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blog.t3live.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cb9d48ddf1a79dac82367bb5c22611feaedc4d64d36c4bdb145788669605ab60?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cb9d48ddf1a79dac82367bb5c22611feaedc4d64d36c4bdb145788669605ab60?s=96&d=mm&r=g","caption":"Daniel Darrow"},"url":"https:\/\/blog.t3live.com\/author\/daniel-darrow\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts\/38681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/comments?post=38681"}],"version-history":[{"count":1,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts\/38681\/revisions"}],"predecessor-version":[{"id":38682,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts\/38681\/revisions\/38682"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/media\/34095"}],"wp:attachment":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/media?parent=38681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/categories?post=38681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/tags?post=38681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}